Cynosure: PicoSure Laser Gets Marketing Authorization In Korea & Taiwan

(RTTNews) - Cynosure Inc. (CYNO) announced that its PicoSure Picosecond Laser has received marketing authorization in Korea from Ministry of Food and Drug Safety, and in Taiwan from the Taiwan Food and Drug Administration, or TFDA. The product will be marketed through the company's direct sales force in Korea and through its third-party distributor in Taiwan.

The TFDA granted marketing authorization to two other Cynosure products: Smartlipo Triplex LaserBodySculpting Workstation, a laser-assisted lipolysis system designed to disrupt fat cells and tighten tissue through tissue coagulation; and Apogee+, a 755 nm Alexandrite laser for removal of hair and epidural lesions on a wide range of skin types.